0001479290-13-000003.txt : 20131023 0001479290-13-000003.hdr.sgml : 20131023 20131023164740 ACCESSION NUMBER: 0001479290-13-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20131023 DATE AS OF CHANGE: 20131023 EFFECTIVENESS DATE: 20131023 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Revance Therapeutics, Inc. CENTRAL INDEX KEY: 0001479290 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770551645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-205127 FILM NUMBER: 131166142 BUSINESS ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-742-3400 MAIL ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 D 1 primary_doc.xml X0707 D LIVE 0001479290 Revance Therapeutics, Inc. 7555 GATEWAY BLVD. NEWARK CA CALIFORNIA 94560 510-742-3400 DELAWARE None None Corporation true Daniel L. Browne 7555 Gateway Boulevard Newark CA CALIFORNIA 94560 Executive Officer Director Ronald Eastman 7555 Gateway Boulevard Newark CA CALIFORNIA 94560 Director Vicente Trelles 7555 Gateway Boulevard Newark CA CALIFORNIA 94560 Director Robert Byrnes 7555 Gateway Boulevard Newark CA CALIFORNIA 94560 Director Phyllis Gardner 7555 Gateway Boulevard Newark CA CALIFORNIA 94560 Director Jim Glasheen 7555 Gateway Boulevard Newark CA CALIFORNIA 94560 Director Frank Kung 7555 Gateway Boulevard Newark CA CALIFORNIA 94560 Director Jonathan Tunnicliffe 7555 Gateway Boulevard Newark CA CALIFORNIA 94560 Director Pharmaceuticals Decline to Disclose 06b false 2013-10-08 false true true true false 0 30000000 10000000 20000000 false 4 0 0 0 false Revance Therapeutics, Inc. /s/ Lauren Silvernail Lauren Silvernail Chief Financial Officer 2013-10-22